Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,057 | 142,467 | 154,924 | 164,235 | 178,391 |
| Other current assets | 2,308 | 1,522 | 1,574 | 3,261 | 2,915 |
| TOTAL | $130,365 | $143,989 | $156,498 | $167,496 | $181,306 |
| Non-Current Assets | |||||
| PPE Net | 6,227 | 6,452 | 6,257 | 6,113 | 5,110 |
| Intangibles | 73 | 128 | 183 | 238 | 293 |
| Other Non-Current Assets | 12,461 | 12,694 | 12,996 | 13,176 | 13,394 |
| TOTAL | $18,761 | $19,274 | $19,436 | $19,527 | $18,797 |
| Total Assets | $149,126 | $163,263 | $175,934 | $187,023 | $200,103 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,325 | 7,415 | 7,774 | 6,407 | 7,308 |
| TOTAL | $7,596 | $8,636 | $8,996 | $7,584 | $8,407 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,371 | 11,696 | 12,004 | 12,300 | 12,606 |
| TOTAL | $11,437 | $11,763 | $12,072 | $12,368 | $12,728 |
| Total Liabilities | $19,033 | $20,399 | $21,068 | $19,952 | $21,135 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,125 | 2,125 | 2,121 | 2,121 | 2,117 |
| Retained earnings | -408,849 | -393,498 | -378,331 | -362,885 | -347,756 |
| TOTAL | $130,093 | $142,864 | $154,866 | $167,071 | $178,968 |
| Total Liabilities And Equity | $149,126 | $163,263 | $175,934 | $187,023 | $200,103 |